GE HealthCare Technologies’ CTO Kass-Hout Taha forfeited 2,940 shares at $71.23 per share across two transactions on 2026-09-01. Investors can track the reported post-transaction ownership position, which stood at 89,969 GE HealthCare shares after the forfeitures.
Key Highlights
- Kass-Hout Taha serves as chief technology officer of GE HealthCare Technologies Inc.
- Kass-Hout Taha owned 89,969 shares after the transactions.
- Both transactions carried SEC transaction code F.
GE HealthCare Technologies Inc. (NASDAQ: GEHC) chief technology officer Kass-Hout Taha forfeited 2,940 shares at $71.23 per share across two transactions. The transactions took place on 1 September 2026. Kass-Hout Taha’s reported ownership after the transactions was 89,969 shares.
Two Transactions Priced at $71.23 Per Share
The share forfeitures were recorded in two separate transactions involving GE HealthCare stock. Each transaction carried SEC transaction code F. The combined total was 2,940 shares, with the reported price set at $71.23 per share. The transactions concern GE HealthCare Technologies Inc. common shares.
That post-transaction figure is the reported ownership position associated with the share forfeitures.
FAQs
Q: How many GE HealthCare shares did Kass-Hout Taha forfeit?
A: Kass-Hout Taha forfeited 2,940 GE HealthCare shares in two separate transactions. The transactions were priced at $71.23 per share on 1 September 2026.
Q: What was Kass-Hout Taha’s GEHC share ownership afterward?
A: Kass-Hout Taha owned 89,969 GE HealthCare shares after the transactions. The filing reports this as the post-transaction ownership position following the two share forfeiture transactions on 1 September 2026.
Q: When did the GE HealthCare CTO share transactions occur?
A: The GE HealthCare CTO share transactions occurred on 1 September 2026. Both transactions carried SEC transaction code F and involved the reported share forfeitures.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.